Physician profile
Willie A Ng
NPI 1144384223
$1,818.48
in general payments reported to CMS, 2019-2025
17 companies · $78.80 in 2025
The $78.80 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $110 · 2020: $222 · 2021: $296 · 2022: $314 · 2023: $233 · 2024: $565 · 2025: $78.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $876.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $876.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $410.01 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $256.35 | 2020-2024 | Vaxelis, Vaxneuvance, Gardasil 9 |
| Sanofi Pasteur INC. | $205.53 | 2021-2024 | |
| Cranial Technologies, INC | $158.54 | 2020-2024 | Doc Band |
| Biomerieux INC | $132.00 | 2024 | |
| Sanofi-Aventis U.S. LLC | $123.97 | 2024 | |
| Ironshore Pharmaceuticals INC. | $79.28 | 2019-2020 | |
| Tris Pharma INC | $71.23 | 2019-2021 | |
| Seqirus USA INC | $66.73 | 2021-2024 | Flucelvax |
| Takeda Pharmaceuticals U.S.A., INC. | $65.48 | 2020-2022 | |
| Glaxosmithkline, LLC. | $64.22 | 2019-2023 | Bexsero |
| Kaleo, INC. | $53.67 | 2020-2023 | Auvi-Q |
| Alk-Abello, INC | $42.15 | 2021-2024 | Ragwitek, Grastek, Odactra |
| Neos Therapeutics, LP | $29.98 | 2024-2025 | Cotempla Xr-Odt, Adzenys Xr-Odt |
| Astrazeneca Pharmaceuticals LP | $23.07 | 2024 | Flumist Quadrivalent |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermira, INC. | $18.14 | 2020 | |
| Shire North American Group INC | $18.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Willie Ng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.